Considering Psychosocial Factors When Investigating Blood Pressure in Patients with Short Sleep Duration: A Propensity Score Matched Analysis

Ningjing Qian, Dandan Yang, Huajun Li, Siyin Ding, Xia Yu, Qingqiu Fan, Zhebin Yu, Shenfeng Ye, Hualiang Yu, Yaping Wang, Xiaohong Pan, Ningjing Qian, Dandan Yang, Huajun Li, Siyin Ding, Xia Yu, Qingqiu Fan, Zhebin Yu, Shenfeng Ye, Hualiang Yu, Yaping Wang, Xiaohong Pan

Abstract

Few studies have considered psychosocial characteristics when investigating the associations between sleep duration and blood pressure (BP). In this study, we took propensity score matching (PSM) to adjust for psychosocial characteristics when comparing BP between individuals with short sleep duration and those with normal sleep duration. A total of 429 participants were included. 72 participants with sleep duration ≤6 h and 65 participants with sleep duration >6 h were matched after PSM. We compared office BP, 24-hour BP, and prevalence of hypertension in the populations before and after PSM, respectively. In the unmatched population, participants with sleep duration ≤6 h were observed with higher office diastolic BP (DBP) and 24-h systolic BP (SBP)/DBP (all P < 0.05). In the matched populations, the differences between the two groups (sleep duration ≤6 h vs. sleep duration >6 h) in office DBP (88.4 ± 10.9 vs. 82.5 ± 11.1 mm Hg; P=0.002), 24-h SBP (134.7 ± 12.0 vs. 129.3 ± 11.6 mm Hg; P=0.009), and 24-h DBP (83.4 ± 9.9 vs. 78.1 ± 10.1 mm Hg; P=0.002) become more significant. Participants with sleep duration ≤6 h only show higher prevalence of hypertension based on 24-h BP data, while analysis after PSM further revealed that these with sleep duration ≤6 h presented about 20% higher prevalence of elevated BP up to office diagnosed hypertension threshold. Therefore, psychosocial characteristics accompanied with short sleep duration should be fully valued in individuals at risks for elevated BP. This trial is registered with NCT03866226.

Conflict of interest statement

The authors declare no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Copyright © 2021 Ningjing Qian et al.

Figures

Figure 1
Figure 1
The selection flowchart for the study participants. ABPM indicates ambulatory blood pressure monitoring; BP, blood pressure; GAD-7, Generalized Anxiety Disorder Scale-7; PHQ-9, Patient Health Questionnaire-9; FIRST, Ford Insomnia Response to Stress Test; PSQI, Pittsburgh Sleep Quality Index.

References

    1. Kario K., Shin J., Chen C. H., et al. Expert panel consensus recommendations for ambulatory blood pressure monitoring in Asia: the HOPE Asia Network. Journal of Clinical Hypertension . 2019;21(9):1250–1283. doi: 10.1111/jch.13652.
    1. Williams B., Mancia G., Spiering W. ESC/ESH Guidelines for the management of arterial hypertension. European Heart Journal . 2018;39(33):3021–3104. doi: 10.1093/eurheartj/ehy439.
    1. Unger T., Borghi C., Charchar F., et al. 2020 international society of hypertension global hypertension practice guidelines. Hypertension . 2020;75(6):1334–1357. doi: 10.1161/hypertensionaha.120.15026.
    1. Zhou B., Carrillo-Larco R. M., Danaei G. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. The Lancet . 2021;398
    1. Muntner P., Shimbo D., Carey R. M., et al. Measurement of blood pressure in humans: a scientific statement from the American heart association. Hypertension . 2019;73(5):e35–e66. doi: 10.1161/HYP.0000000000000087.
    1. Wang Z., Chen Z., Zhang L., et al. Status of hypertension in China. Circulation . 2018;137(22):2344–2356. doi: 10.1161/circulationaha.117.032380.
    1. Whelton P. K., Carey R. M., Aronow W. S. ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American college of cardiology/American heart association task force on clinical practice guidelines. Circulation . 2017;138(17):e426–e483.
    1. Pepin J.-L., Borel A.-L., Tamisier R., Baguet J.-P., Levy P., Dauvilliers Y. Hypertension and sleep: overview of a tight relationship. Sleep Medicine Reviews . 2014;18(6):509–519. doi: 10.1016/j.smrv.2014.03.003.
    1. Jarrin D. C., Alvaro P. K., Bouchard M.-A., Jarrin S. D., Drake C. L., Morin C. M. Insomnia and hypertension: a systematic review. Sleep Medicine Reviews . 2018;41:3–38. doi: 10.1016/j.smrv.2018.02.003.
    1. Vgontzas A. N., Fernandez-Mendoza J., Liao D., Bixler E. O. Insomnia with objective short sleep duration: the most biologically severe phenotype of the disorder. Sleep Medicine Reviews . 2013;17(4):241–254. doi: 10.1016/j.smrv.2012.09.005.
    1. Makarem N., Shechter A., Carnethon M. R., Mullington J. M., Hall M. H., Abdalla M. Sleep duration and blood pressure: recent advances and future directions. Current Hypertension Reports . 2019;21(5):p. 33. doi: 10.1007/s11906-019-0938-7.
    1. Bathgate C. J., Fernandez-Mendoza J. Insomnia, short sleep duration, and high blood pressure: recent evidence and future directions for the prevention and management of hypertension. Current Hypertension Reports . 2018;20(6):p. 52. doi: 10.1007/s11906-018-0850-6.
    1. Fernandez-Mendoza J., Vgontzas A. N., Liao D., et al. Insomnia with objective short sleep duration and incident hypertension. Hypertension . 2012;60(4):929–935. doi: 10.1161/hypertensionaha.112.193268.
    1. Vgontzas A. N., Liao D., Bixler E. O., Chrousos G. P., Vela-Bueno A. Insomnia with objective short sleep duration is associated with a high risk for hypertension. Sleep . 2009;32(4):491–497. doi: 10.1093/sleep/32.4.491.
    1. Bathgate C. J., Edinger J. D., Wyatt J. K., Krystal A. D. Objective but not subjective short sleep duration associated with increased risk for hypertension in individuals with insomnia. Sleep . 2016;39(5):1037–1045. doi: 10.5665/sleep.5748.
    1. Johann A. F., Hertenstein E., Kyle S. D., et al. Insomnia with objective short sleep duration is associated with longer duration of insomnia in the Freiburg Insomnia Cohort compared to insomnia with normal sleep duration, but not with hypertension. PLoS One . 2017;12(7):p. e0180339. doi: 10.1371/journal.pone.0180339.
    1. Vozoris N. T. The relationship between insomnia symptoms and hypertension using United States population-level data. Journal of Hypertension . 2013;31(4):663–671. doi: 10.1097/hjh.0b013e32835ed5d0.
    1. Baglioni C., Nanovska S., Regen W., et al. Sleep and mental disorders: a meta-analysis of polysomnographic research. Psychological Bulletin . 2016;142(9):969–990. doi: 10.1037/bul0000053.
    1. Baglioni C., Spiegelhalder K., Lombardo C., Riemann D. Sleep and emotions: a focus on insomnia. Sleep Medicine Reviews . 2010;14(4):227–238. doi: 10.1016/j.smrv.2009.10.007.
    1. Walton D. M., Pourkazemi F., Ghodrati M., Elliott J. M. A mediational analysis of stress, inflammation, sleep, and pain in acute musculoskeletal trauma. The Clinical Journal of Pain . 2020;36(3):197–202. doi: 10.1097/ajp.0000000000000790.
    1. Buysse D. J., Reynolds C. F., Monk T. H., Berman S. R., Kupfer D. J. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Research . 1989;28(2):193–213. doi: 10.1016/0165-1781(89)90047-4.
    1. Lu K., Chen J., Wu S., Chen J., Hu D. Interaction of sleep duration and sleep quality on hypertension prevalence in adult Chinese males. Journal of Epidemiology . 2015;25(6):415–422. doi: 10.2188/jea.je20140139.
    1. Consensus Conference Panel, Watson N. F., Badr M. S. Joint consensus statement of the American academy of sleep medicine and sleep research society on the recommended amount of sleep for a healthy adult: methodology and discussion. Sleep . 2015;38(8):1161–1183.
    1. Löwe B., Decker O., Müller S., et al. Validation and standardization of the generalized anxiety disorder screener (GAD-7) in the general population. Medical Care . 2008;46(3):266–274. doi: 10.1097/MLR.0b013e318160d093.
    1. Tian Z., Huang Y., Yue T., et al. A Chinese cross-sectional study on depression and anxiety symptoms in patients with psoriasis vulgaris. Psychology Health & Medicine . 2019;24(3):269–280. doi: 10.1080/13548506.2018.1529323.
    1. Kroenke K., Spitzer R. L., Williams J. B. W. The PHQ-9. Journal of General Internal Medicine . 2001;16(9):606–613. doi: 10.1046/j.1525-1497.2001.016009606.x.
    1. Zhang Y., Ting R., Lam M., et al. Measuring depressive symptoms using the Patient Health Questionnaire-9 in Hong Kong Chinese subjects with type 2 diabetes. Journal of Affective Disorders . 2013;151(2):660–666. doi: 10.1016/j.jad.2013.07.014.
    1. Ellis J. G., Gehrman P., Espie C. A., Riemann D., Perlis M. L. Acute insomnia: current conceptualizations and future directions. Sleep Medicine Reviews . 2012;16(1):5–14. doi: 10.1016/j.smrv.2011.02.002.
    1. Kalmbach D. A., Pillai V., Arnedt J. T., Drake C. L. Identifying at-risk individuals for insomnia using the Ford insomnia response to stress test. Sleep . 2016;39(2):449–456. doi: 10.5665/sleep.5462.
    1. Yang Y., Luo X., Paudel D., Zhang J., Li S. X., Zhang B. Effects of e-aid cognitive behavioural therapy for insomnia (eCBTI) to prevent the transition from episodic insomnia to persistent insomnia: study protocol for a randomised controlled trial. BMJ Open . 2019;9(11):p. e033457. doi: 10.1136/bmjopen-2019-033457.
    1. Kalmbach D. A., Anderson J. R., Drake C. L. The impact of stress on sleep: pathogenic sleep reactivity as a vulnerability to insomnia and circadian disorders. Journal of Sleep Research . 2018;27(6):p. e12710. doi: 10.1111/jsr.12710.
    1. Deng H. B., Tam T., Zee B. C., et al. Short sleep duration increases metabolic impact in healthy adults: a population-based cohort study. Sleep . 2017;40(10) doi: 10.1093/sleep/zsx130.
    1. Guo X., Zheng L., Wang J., et al. Epidemiological evidence for the link between sleep duration and high blood pressure: a systematic review and meta-analysis. Sleep Medicine . 2013;14(4):324–332. doi: 10.1016/j.sleep.2012.12.001.
    1. Kalmbach D. A., Pillai V., Arnedt J. T., Drake C. L. DSM-5 insomnia and short sleep: comorbidity landscape and racial disparities. Sleep . 2016;39(12):2101–2111. doi: 10.5665/sleep.6306.
    1. Zhan Y., Chen R., Zhang F., et al. Insomnia and its association with hypertension in a community-based population in China: a cross-sectional study. Heart Asia . 2014;6(1):88–93. doi: 10.1136/heartasia-2013-010440.
    1. Huang Y., Su Y., Jiang Y., Zhu M. Sex differences in the associations between blood pressure and anxiety and depression scores in a middle-aged and elderly population: the Irish Longitudinal Study on Ageing (TILDA) Journal of Affective Disorders . 2020;274:118–125. doi: 10.1016/j.jad.2020.05.133.
    1. Johnson H. M. Anxiety and hypertension: is there a link? A literature review of the comorbidity relationship between anxiety and hypertension. Current Hypertension Reports . 2019;21(9):p. 66. doi: 10.1007/s11906-019-0972-5.
    1. Liu M.-Y., Li N., Li W. A., Khan H. Association between psychosocial stress and hypertension: a systematic review and meta-analysis. Neurological Research . 2017;39(6):573–580. doi: 10.1080/01616412.2017.1317904.
    1. Maatouk I., Herzog W., Böhlen F., et al. Association of hypertension with depression and generalized anxiety symptoms in a large population-based sample of older adults. Journal of Hypertension . 2016;34(9):1711–1720. doi: 10.1097/hjh.0000000000001006.
    1. Booth J. N., Muntner P., Abdalla M., et al. Differences in night-time and daytime ambulatory blood pressure when diurnal periods are defined by self-report, fixed-times, and actigraphy. Journal of Hypertension . 2016;34(2):235–243. doi: 10.1097/hjh.0000000000000791.
    1. Buysse D. J. Insomnia. JAMA . 2013;309(7):706–716. doi: 10.1001/jama.2013.193.
    1. Mahmood A., Ray M., Dobalian A., Ward K. D., Ahn S. Insomnia symptoms and incident heart failure: a population-based cohort study. European Heart Journal . 2021;42 doi: 10.1093/eurheartj/ehab500.

Source: PubMed

3
Abonneren